Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
FLNA

FILANA THERAPEUTICS (FLNA) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $0.82 +1.2% on the day -80.4% over 12 months 52-week range $0.68 – $4.64

Share price and insider trades

FLNA closeInsider buyInsider sale
0246NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $24,940 on 2025-11-24 · Robert Eugene Anderson Jr.Bought $78,196 on 2026-09-28 · Richard BarryBought $92,000 on 2026-09-30 · Richard BarryBought $186,132 on 2026-09-29 · Richard BarryBought $201,809 on 2025-11-19 · Richard BarryBought $414,000 on 2025-11-20 · Richard Barry
Bought, 12 months$997K
Sold, 12 months$0
Insiders buying2
Insiders selling0

FILANA THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $997K and 0 sold $0 of FLNA stock on the open market.

FLNA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2025: $40K bought (1 trades)$40KQ3 2025Q4 2025: $641K bought (3 trades)$641KQ4 2025Q1 2026Q2 2026Q3 2026: $356K bought (3 trades)$356KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$356K3—0
Q2 2026—0—0
Q1 2026—0—0
Q4 2025$641K3—0
Q3 2025$40K1—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$39.5MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day0.3×Last 5 sessions
Insiders' paper profit−$508KOn all tracked purchases -48.9%

Summary

Over the past 12 months, 2 FILANA THERAPEUTICS, INC. insiders reported open-market purchases totaling $997K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Richard Barry (CEO, President) has the highest Insider Score at 15.

FLNA stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 1SEC Richard BarryCEO, President Buy 206,8131,237,964 held (+20%) $0.90 $186K -8.9% 15
Oct 1SEC Richard BarryCEO, President Buy 100,0001,337,964 held (+8%) $0.92 $92K -10.9% 15
Sep 30SEC Richard BarryCEO, President Buy 93,0911,031,151 held (+10%) $0.84 $78K -2.4% 15
Nov 25SEC Robert Eugene Anderson Jr.Director Buy 8,600new position $2.90 $25K -71.7% —
Nov 24SEC Richard BarryCEO, President Buy 150,000938,060 held (+19%) $2.76 $414K -70.3% 15
Nov 20SEC Richard BarryCEO, President Buy 73,385788,060 held (+10%) $2.75 $202K -70.2% 15
Oct 2SEC Robert Christopher CookCOO Buy 13,725new position $2.91 $40K -71.8% —

Insiders at FILANA THERAPEUTICS, INC.

InsiderBoughtSoldLast filingScore
Richard BarryCEO, President $972K — Oct 1, 2026 15
Robert Christopher CookCOO $40K — Oct 2, 2025 —
Robert Eugene Anderson Jr.Director $25K — Nov 25, 2025 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

FLNA stock: common questions

Are FILANA THERAPEUTICS, INC. insiders buying FLNA stock?

In the past 12 months, 2 insiders reported open-market purchases of FLNA worth $997K. The latest was CEO, President Richard Barry bought $186K of FLNA at $0.90 — raises the stake by 20%.

Are FILANA THERAPEUTICS, INC. insiders selling FLNA stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is FLNA's 52-week range?

Over the past year FLNA has traded between $0.68 and $4.64. It last closed at $0.82 on Oct 9, 2026.